Quick Answer
COLLEGIUM PHARMACEUTICAL, INC reported Net Income of $62.87 million for fiscal year 2025.
COLLEGIUM PHARMACEUTICAL, INC Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | $62.87M | -9.1% |
| 2024 | $69.19M | +43.7% |
| 2023 | $48.16M | +292.6% |
| 2022 | -$25.00M | -135.0% |
| 2021 | $71.52M | +167.3% |
| 2020 | $26.75M | +217.7% |
| 2019 | -$22.72M | +41.9% |
| 2018 | -$39.13M | +47.7% |
| 2017 | -$74.86M | +20.5% |
| 2016 | -$94.18M | -245.5% |
| 2015 | -$27.25M | -52.1% |
| 2014 | -$17.92M | -10.6% |
| 2013 | -$16.20M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $31.51M | +237.5% | +162.9% |
| June 30, 2025 | $11.98M | -38.9% | +395.8% |
| March 31, 2025 | $2.42M | -91.3% | -74.1% |
| September 30, 2024 | $9.34M | -54.8% | -52.4% |
| June 30, 2024 | $19.61M | +50.7% | -29.3% |
| March 31, 2024 | $27.71M | +259.0% | +34.3% |
| September 30, 2023 | $20.63M | +4415.1% | +58.6% |
| June 30, 2023 | $13.01M | +350.6% | +174.6% |
- COLLEGIUM PHARMACEUTICAL, INC showed a decrease of -9.1% in Net Income compared to the prior fiscal year.
- Over the 2013–2025 period, COLLEGIUM PHARMACEUTICAL, INC’s net income has grown by 488.2% (from -$16.20 million to $62.87 million).
- The most recent figure is from COLLEGIUM PHARMACEUTICAL, INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: